Volume 35, Issue 2 pp. 495-498
CASE REPORT

In-situ recurrence of the primary cardiac dedifferentiated liposarcoma: To resect or not?

Jiayu Shen MD

Jiayu Shen MD

Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

Jiayu Shen, Zhi Fang, and Yahan Zhang contributed equally to this study.

Search for more papers by this author
Zhi Fang MD

Zhi Fang MD

Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

Jiayu Shen, Zhi Fang, and Yahan Zhang contributed equally to this study.

Search for more papers by this author
Yahan Zhang MD

Yahan Zhang MD

Department of Pathology, West China Hospital, Sichuan University, Chengdu, China

Jiayu Shen, Zhi Fang, and Yahan Zhang contributed equally to this study.

Search for more papers by this author
Jianglong Hou MD, PhD

Corresponding Author

Jianglong Hou MD, PhD

Correspondence Jianglong Hou, MD, PhD, Department of Cardiovascular Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041 Sichuan, China.

Email: [email protected]

Search for more papers by this author
First published: 05 December 2019
Citations: 2

Abstract

Dedifferentiated liposarcoma (DDLPS) is a rare type of neoplasm which can originally rise in cardiac chamber. Owing to the recurrence and distant metastasis, the prognosis of the primary malignant cardiac tumor is extremely poor and remains a challenge for cardiac surgeons. Here, we report a patient with an intracavitary mass which was diagnosed as DDLPS by postoperative pathological examinations, experienced repeated in-situ recurrence of the malignant cardiac tumor.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

DATA AVAILABILITY STATEMENT

All data generated or analyzed during this study are included in this published study.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.